Andreas Seidl

Director Técnico/Científico/I+D en FORMYCON AG .

Health Technology

Consumer Services

Health Services

Perfil

Andreas Seidl currently works at Formycon AG, as Chief Scientific Officer from 2022.
Dr. Seidl also formerly worked at LEUKOCARE AG, as Chief Operating Officer from 2019 to 2022, Hexal Biotech GmbH, as Head-Analytics & Quality Control from 2002 to 2010, and Novartis AG, as Site Manager from 2010 to 2015.
Dr. Seidl received his doctorate degree from Universität Konstanz.

Cargos activos de Andreas Seidl

Empresas	Cargo	Inicio
FORMYCON AG	Director Técnico/Científico/I+D	01/07/2022

Todos los cargos activos de Andreas Seidl

Antiguos cargos conocidos de Andreas Seidl.

Empresas	Cargo	Fin
LEUKOCARE AG LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions	Director de Operaciones	01/01/2022
NOVARTIS AG	Corporate Officer/Principal	01/01/2015

Ver el detalle de la experiencia de Andreas Seidl.

Formación de Andreas Seidl.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andreas Seidl.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Universität Konstanz Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LEUKOCARE AG LEUKOCARE AG Medical/Nursing ServicesHealth Services Develops protein stabilization and protection solutions	Health Services
Formycon AG Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products	Health Technology